Inovio Pharmaceuticals, Inc. (INO)
1.56
+0.02
(+1.30%)
USD |
NASDAQ |
Mar 26, 10:42
Inovio Pharmaceuticals Cash from Investing (Quarterly) : -0.0582M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vaxart, Inc. | 1.989M |
| Stereotaxis, Inc. | -0.07M |
| Capricor Therapeutics, Inc. | 43.09M |
| Allogene Therapeutics, Inc. | 33.61M |
| Silvergate Capital Corp. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.37M |
| Cash from Financing (Quarterly) | 27.13M |
| Free Cash Flow | -88.92M |
| Free Cash Flow Per Share (Quarterly) | -0.2826 |
| Free Cash Flow to Equity (Quarterly) | -18.85M |
| Free Cash Flow to Firm (Quarterly) | -19.50M |
| Free Cash Flow Yield | -114.8% |